IPOs under microscope as Chr Hansen and Life get ready
The EMEA IPO market will face a stern test next week when Danish biotech firm Chr Hansen and South African healthcare group Life price their IPOs, which together hope to raise around $1.8bn.
No deals were due to be priced this week so Europe was spared an IPO wipeout as markets swung wildly. The EuroStoxx 50 index went from 2,764.31 on May 12 to 2,488.50 on Tuesday — a fall of 10% — before recovering later during the week to close
...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Or sign up for a trial to gain full access to the entire site for a limited period.
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
